- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Testing the evolution process of prostate-specific antigen in early stage prostate cancer: What is the proper underlying model? - Abstract
September 5, 2011
Blood donors: An ideal population to study the PSA value and the incidence of prostate cancer in healthy population - Abstract
September 5, 2011
Residual prostatic tumour in the surgical bed following radical prostatectomy in organ-confined prostate cancer: Possible prognostic significance - Abstract
September 5, 2011
Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States - Abstract
September 2, 2011
Vegetable and fruit intake after diagnosis and risk of prostate cancer progression - Abstract
September 2, 2011
Smoking and adverse outcomes at radical prostatectomy - Abstract
September 2, 2011
Active surveillance for prostate cancer: Progress and promise - Abstract
September 2, 2011
The changing therapeutic landscape of castration-resistant prostate cancer - Abstract
September 2, 2011
Cancer immunology-analysis of host and tumor factors for personalized medicine - Abstract
September 2, 2011
PSA affects prostate cancer cell invasion in vitro and induces an osteoblastic phenotype in bone in vivo - Abstract
September 2, 2011
Inhibition of Src family kinases and receptor tyrosine kinases by dasatinib: Possible combinations in solid tumors - Abstract
September 2, 2011
Multi-media support for informed/shared decision-making before and after a cancer diagnosis - Abstract
September 1, 2011
Reirradiation of prostate cancer with rectum preservation: Eradicative high-dose-rate brachytherapy with natural type hyaluronate injection - Abstract
September 1, 2011
A novel indium-111-labeled gonadotropin-releasing hormone peptide for human prostate cancer imaging - Abstract
September 1, 2011
Use of Surveillance, Epidemiology, and End Results-Medicare data to conduct case-control studies of cancer among the US elderly - Abstract
September 1, 2011